首页> 外文期刊>FEBS Open Bio >Dual binding mode of antithyroid drug methimazole to mammalian heme peroxidases – structural determination of the lactoperoxidase–methimazole complex at 1.97 ? resolution
【24h】

Dual binding mode of antithyroid drug methimazole to mammalian heme peroxidases – structural determination of the lactoperoxidase–methimazole complex at 1.97 ? resolution

机译:抗甲状腺药甲巯咪唑与哺乳动物血红素过氧化物酶的双重结合模式–乳过氧化物酶-甲咪唑复合物的结构测定为1.97?解析度

获取原文
           

摘要

Lactoperoxidase (LPO, EC 1.11.1.7 ) is a member of the mammalian heme peroxidase family which also includes thyroid peroxidase (TPO). These two enzymes have a sequence homology of 76%. The structure of LPO is known but not that of TPO. In order to determine the mode of binding of antithyroid drugs to thyroid peroxidase, we have determined the crystal structure of LPO complexed with an antithyroid drug, methimazole (MMZ) at 1.97 ? resolution. LPO was isolated from caprine colostrum, purified to homogeneity and crystallized with 20% poly(ethylene glycol)‐3350. Crystals of LPO were soaked in a reservoir solution containing MMZ. The structure determination showed the presence of two crystallographically independent molecules in the asymmetric unit. Both molecules contained one molecule of MMZ, but with different orientations. MMZ was held tightly between the heme moiety on one side and the hydrophobic parts of the side chains of Arg255, Glu258, and Leu262 on the opposite side. The back of the cleft contained the side chains of Gln105 and His109 which also interacted with MMZ. In both orientations, MMZ had identical buried areas and formed a similar number of interactions. It appears that the molecules of MMZ can enter the substrate‐binding channel of LPO in two opposite orientations. But once they reach the distal heme pocket, their orientations are frozen due to equally tight packing of MMZ in both orientations. This is a novel example of an inhibitor binding to an enzyme with two orientations at the same site with nearly equal occupancies.
机译:乳过氧化物酶(LPO,EC 1.11.1.7)是哺乳动物血红素过氧化物酶家族的成员,其还包括甲状腺过氧化物酶(TPO)。这两种酶具有76%的序列同源性。 LPO的结构是已知的,但TPO的结构不是。为了确定抗甲状腺药物与甲状腺过氧化物酶的结合方式,我们确定了LPO与抗甲状腺药物甲巯咪唑(MMZ)的晶体结构为1.97?解析度。 LPO是从山羊初乳中分离出来的,纯化至均一并用20%聚乙二醇3350结晶。将LPO晶体浸泡在含有MMZ的储液中。结构确定表明在不对称单元中存在两个晶体学独立的分子。两个分子都包含一个MMZ分子,但方向不同。 MMZ紧紧固定在一侧的血红素部分与另一侧的Arg255,Glu258和Leu262侧链的疏水部分之间。裂隙的背面包含Gln105和His109的侧链,它们也与MMZ相互作用。在两个方向上,MMZ具有相同的掩埋区并形成相似数量的相互作用。看来MMZ分子可以两个相反的方向进入LPO的底物结合通道。但是一旦它们到达血红素远端囊袋,由于MMZ在两个方向上的紧密堆积,它们的方向就被冻结了。这是抑制剂与酶结合的新颖例子,该酶在相同位点具有几乎相同的占据率的两个方向。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号